DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 158 filers reported holding DIPLOMAT PHARMACY INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $270,000 | -4.3% | 67,460 | +17.0% | 0.00% | – |
| Q3 2019 | $282,000 | -52.7% | 57,634 | -41.1% | 0.00% | – |
| Q2 2019 | $596,000 | -77.1% | 97,907 | -78.1% | 0.00% | – |
| Q1 2019 | $2,597,000 | -61.4% | 446,840 | -10.6% | 0.00% | -100.0% |
| Q4 2018 | $6,727,000 | -44.7% | 499,789 | -20.3% | 0.00% | -50.0% |
| Q3 2018 | $12,165,000 | -66.3% | 626,785 | -55.6% | 0.00% | -66.7% |
| Q2 2018 | $36,119,000 | +307.7% | 1,413,176 | +221.5% | 0.01% | +500.0% |
| Q1 2018 | $8,859,000 | -35.3% | 439,614 | -35.6% | 0.00% | -50.0% |
| Q4 2017 | $13,698,000 | -12.7% | 682,542 | -9.9% | 0.00% | 0.0% |
| Q3 2017 | $15,684,000 | +111.2% | 757,300 | +50.9% | 0.00% | +100.0% |
| Q2 2017 | $7,427,000 | +10.2% | 501,860 | +18.7% | 0.00% | 0.0% |
| Q1 2017 | $6,742,000 | +136.5% | 422,697 | +86.8% | 0.00% | 0.0% |
| Q4 2016 | $2,851,000 | -14.5% | 226,279 | +90.2% | 0.00% | 0.0% |
| Q3 2016 | $3,333,000 | -11.6% | 118,985 | +10.5% | 0.00% | 0.0% |
| Q2 2016 | $3,769,000 | +19.9% | 107,707 | -6.1% | 0.00% | 0.0% |
| Q1 2016 | $3,144,000 | -41.6% | 114,742 | -27.1% | 0.00% | 0.0% |
| Q4 2015 | $5,386,000 | +231.7% | 157,383 | +178.6% | 0.00% | – |
| Q3 2015 | $1,624,000 | +316.4% | 56,499 | +547.9% | 0.00% | – |
| Q2 2015 | $390,000 | -13.1% | 8,721 | -32.8% | 0.00% | – |
| Q1 2015 | $449,000 | +441.0% | 12,985 | +329.4% | 0.00% | – |
| Q4 2014 | $83,000 | – | 3,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|